{
    "clinical_study": {
        "@rank": "95730", 
        "arm_group": [
            {
                "arm_group_label": "insulin nasal spray", 
                "arm_group_type": "Experimental", 
                "description": "160 Units of human insulin as nasal spray"
            }, 
            {
                "arm_group_label": "Placebo nasal spray", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Nasalspray containing placebo solution"
            }
        ], 
        "brief_summary": {
            "textblock": "The researchers will investigate if brain insulin action influences peripheral insulin\n      sensitivity in healthy humans."
        }, 
        "brief_title": "Influence of Brain Insulin Sensitivity on Peripheral Insulin Sensitivity", 
        "condition": "Insulin Sensitivity", 
        "condition_browse": {
            "mesh_term": "Insulin Resistance"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  BMI < 28 kg/m2\n\n          -  normal HbA1c\n\n          -  healthy volunteers\n\n        Exclusion Criteria:\n\n          -  Heparin induced thrombocytopenia (HIT)\n\n          -  metal implants\n\n          -  cardial diseases\n\n          -  anemia\n\n          -  patients taking any kind of drugs"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "35 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01847456", 
            "org_study_id": "SFB 997 A01 WP7"
        }, 
        "intervention": [
            {
                "arm_group_label": "insulin nasal spray", 
                "intervention_name": "human insulin as nasal spray", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo nasal spray", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Insulin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "whole body insulin sensitivity", 
            "insulin action in the brain"
        ], 
        "lastchanged_date": "December 20, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Tuebingen", 
                    "country": "Germany", 
                    "zip": "72074"
                }, 
                "name": "University of Tuebingen, Internal medicine IV"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "Influence of Brain Insulin Sensitivity on Peripheral Insulin Sensitivity", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "We will measure insulin sensitivity by hyperinsulinemic euglycemic clamp before and after nasal spray application. We will compare the post-spray insulin sensitivity between the two condition (insulin nasal spray vs placebo nasal spray). Furthermore, we will compare insulin sensitivity before and after nasal insulin application.", 
            "measure": "Insulin sensitivity as measured by clamp", 
            "safety_issue": "No", 
            "time_frame": "45 minutes to 120 minutes post nasal spray"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01847456"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital Tuebingen", 
            "investigator_full_name": "andreas fritsche", 
            "investigator_title": "Professor of Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Activity of the autonomous nervous system will be estimated by heart rate variability in ECG. We will compare the post-spray autonomous nervous system activity between the two condition (insulin nasal spray vs placebo nasal spray). Furthermore, we will compare autonomous nervous system activity before and after nasal insulin application.", 
            "measure": "Autonomous nervous system activity", 
            "safety_issue": "No", 
            "time_frame": "45 to 120 minutes post spray"
        }, 
        "source": "University Hospital Tuebingen", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital Tuebingen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}